earnings
OC
NASDAQ · OCS
Oculis Holding AG
Healthcare · Biotechnology
$8.66
Up+$0.16 (+1.88%)
Updated Oct 9, 2026, 4:03 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- -8.07
- Dividend yield
- 0.00%
- 52-week range
- $8.30 – $34.48
- Volume
- 452.01K
- Avg. volume
- 99.02K
Price performance · OCS
OCS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
OCS closed at $8.66 after 21 trading sessions, down 23.43% for the selected period.
- Last close
- $8.66
- Period change
- -23.43%
- Period low
- $8.50
- Period high
- $11.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $8.50 | $8.75 | $8.37 | $8.66 | 452.01K |
| Oct 7, 2026 | $8.83 | $8.83 | $8.35 | $8.50 | 173.69K |
| Oct 6, 2026 | $8.61 | $8.80 | $8.30 | $8.72 | 291.65K |
| Oct 5, 2026 | $8.79 | $9.00 | $8.56 | $8.56 | 242K |
| Oct 2, 2026 | $8.82 | $8.8254 | $8.53 | $8.73 | 586.3K |
| Oct 1, 2026 | $9.16 | $9.26 | $8.67 | $8.76 | 578.45K |
| Sep 30, 2026 | $9.20 | $9.48 | $9.02 | $9.34 | 434.74K |
| Sep 29, 2026 | $9.10 | $9.38 | $9.07 | $9.13 | 373.46K |
| Sep 28, 2026 | $9.20 | $9.33 | $9.00 | $9.06 | 266.99K |
| Sep 25, 2026 | $9.71 | $9.71 | $9.10 | $9.27 | 239.61K |
| Sep 24, 2026 | $9.94 | $9.945 | $9.21 | $9.41 | 209.25K |
| Sep 23, 2026 | $10.64 | $10.77 | $9.88 | $9.99 | 143.77K |
| Sep 22, 2026 | $10.27 | $10.84 | $10.26 | $10.71 | 206.77K |
| Sep 21, 2026 | $10.19 | $10.35 | $10.00 | $10.14 | 201.83K |
| Sep 18, 2026 | $10.17 | $10.43 | $9.67 | $10.14 | 412.07K |
| Sep 17, 2026 | $9.90 | $10.155 | $9.85 | $9.98 | 248.06K |
| Sep 16, 2026 | $10.11 | $10.1999 | $9.65 | $9.91 | 314.1K |
| Sep 15, 2026 | $10.60 | $10.61 | $10.00 | $10.07 | 159.31K |
| Sep 14, 2026 | $10.56 | $10.835 | $10.51 | $10.60 | 153.19K |
| Sep 11, 2026 | $11.39 | $11.98 | $10.50 | $10.56 | 226.62K |
| Sep 10, 2026 | $11.34 | $11.60 | $11.00 | $11.31 | 169.33K |
Latest OCS news
The latest Smart Investors Daily articles mentioning OCS.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

